Accepted for Publication: March 20, 2022.
Published: May 26, 2022. doi:10.1001/jamanetworkopen.2022.14163
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Kerkhoff AD et al. JAMA Network Open.
Corresponding Author: Carina Marquez, MD, MPH, Division of HIV, Infectious Diseases Global Medicine, University of California, San Francisco, Zuckerberg San Francisco General Hospital, 995 Potrero Ave, San Francisco, CA 94110 (carina.marquez@ucsf.edu).
Author Contributions: Drs Kerkhoff and Marquez had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Kerkhoff, Susana Rojas, Ribeiro, Jones, Tulier-Laiwa, Petersen, Havlir, Marquez.
Acquisition, analysis, or interpretation of data: Kerkhoff, Black, Susy Rojas, Valencia, Lemus, Payan, Schrom, Jones, Manganelli, Bandi, Chamie, Petersen, Havlir, Marquez.
Drafting of the manuscript: Kerkhoff, Schrom, Havlir, Marquez.
Critical revision of the manuscript for important intellectual content: Kerkhoff, Susana Rojas, Black, Ribeiro, Susy Rojas, Valencia, Lemus, Payan, Jones, Manganelli, Bandi, Chamie, Tulier-Laiwa, Petersen, Havlir, Marquez.
Statistical analysis: Kerkhoff, Petersen.
Obtained funding: Havlir.
Administrative, technical, or material support: Black, Ribeiro, Susy Rojas, Valencia, Lemus, Schrom, Jones, Manganelli, Bandi, Chamie, Havlir.
Supervision: Ribeiro, Payan, Havlir, Marquez.
Conflict of Interest Disclosures: Mr Manganelli reported receiving hourly wages from BayPLS for registration and check-out services at the multidisease testing site, both during the conduct of the study and outside the submitted work. Dr Chamie reported receiving grants from National Institutes of Health outside the submitted work. Dr Havlir reported receiving a supply of COVID-19 tests from Abbvie outside the submitted work. No other disclosures were reported.
Funding/Support: This program was supported by the University of California, San Francisco, John P. McGovern Foundation, and the Chan Zuckerberg Health Initiative.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: We gratefully acknowledge Xzalyn Hernandez, BA, and Erica Vazquez, BA, from the Latino Task Force for COVID-19 for their contributions to health education and linkage to care. We would like to thank Joanna Eveland, MD, and Ricardo Duarte, RN, from San Francisco General Hospital for their contributions to health care linkage; and Bessa Makoni, NP, and Audrey Tang, NP, from Zuckerberg San Francisco General Hospital for their contributions in training community health workers on diabetes and lifestyle modifications. None of these individuals received any form of compensation for their support of or participation in this initiative.
2.Tai
DBG , Sia
IG , Doubeni
CA , Wieland
ML . Disproportionate impact of COVID-19 on racial and ethnic minority groups in the United States: a 2021 update.
J Racial Ethn Heal Disparities; 2021:1-6. doi:
10.1007/s40615-021-01170-wGoogle ScholarCrossref 4.McElfish
PA , Rowland
B , Porter
A ,
et al. Use of community-based participatory research partnerships to reduce COVID-19 disparities among Marshallese Pacific Islander and Latino Communities—Benton and Washington Counties, Arkansas, April-December 2020.
Prev Chronic Dis. 2021;18:E91. doi:
10.5888/pcd18.210124PubMedGoogle ScholarCrossref 5.Brewer
LC , Asiedu
GB , Jones
C ,
et al. Emergency preparedness and risk communication among African American churches: leveraging a community-based participatory research partnership COVID-19 initiative.
Prev Chronic Dis. 2020;17:E158. doi:
10.5888/pcd17.200408PubMedGoogle ScholarCrossref 7.Brewer
LC , Woods
C , Patel
A ,
et al; FAITH! Community Steering Committee COVID-19 Task Force. Establishing a SARS-CoV-2 (COVID-19) drive-through collection site: a community-based participatory research partnership with a federally qualified health center.
Am J Public Health. 2021;111(4):658-662. doi:
10.2105/AJPH.2020.306097PubMedGoogle ScholarCrossref 10.Varma
R , Choudhury
F , Klein
R , Chung
J , Torres
M , Azen
SP ; Los Angeles Latino Eye Study Group. Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study.
Am J Ophthalmol. 2010;149(5):752-761. doi:
10.1016/j.ajo.2009.11.014PubMedGoogle ScholarCrossref 14.Doshi
M , Lopez
WD , Mesa
H ,
et al. Barriers & facilitators to healthcare and social services among undocumented Latino(a)/Latinx immigrant clients: perspectives from frontline service providers in Southeast Michigan.
PLoS One. 2020;15(6):e0233839. doi:
10.1371/journal.pone.0233839PubMedGoogle ScholarCrossref 15.Davidson
MB , Duran
P , Lee
ML . Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos.
Ethn Dis. 2014;24(2):195-199.
PubMedGoogle Scholar 18.Fields
J , Gutierrez
JR , Marquez
C , Rhoads
K , Kushel
M , Fernandez
A ,
et al. Community-academic partnerships to address Covid-19 inequities: lessons from the San Francisco Bay Area.
NEJM Catal. Published online June 23, 2021. doi:
10.1056/CAT.21.0135 27.Porterfield
DS , Din
R , Burroughs
A ,
et al. Screening for diabetes in an African-American community: the Project DIRECT experience.
J Natl Med Assoc. 2004;96(10):1325-1331.
PubMedGoogle Scholar 35.Papastergiou
J , Rajan
A , Diamantouros
A , Zervas
J , Chow
J , Tolios
P . HbA1c testing in the community pharmacy: a new strategy to improve care for patients with diabetes.
Can Pharm J (Ott). 2012;145(4):165-167. doi:
10.3821/145.4.cpj165PubMedGoogle ScholarCrossref 37.Oh
H , Trinh
MP , Vang
C , Becerra
D . Addressing barriers to primary care access for Latinos in the U.S.: an agent-based model.
J Soc Social Work Res. 2020;11(2):165-184. doi:
10.1086/708616Google ScholarCrossref